Skip to main content
Defiance International

Copper(II) aromatic heterocyclic complexes of Gatifloxacin with multi-targeting capabilities for antibacterial therapy and combating antibiotic resistance.

Study record. Bioorganic chemistry, 2024. No summary is published for it.

  • 2024

Authorship

No summary is published for this record. No date is promised for one.

Verification: PMID confirmed at PubMed

This study and its findings belong to the authors cited. Defiance International, a supplier of chemical sequences for research use, keeps this record and makes no claim from its findings.

Verify a lot

PMID confirmed at PubMed

Open declared source

Key facts

Design
Design subtype not established
System
Not reported
Scale
Not reported
Comparator
None reported
Journal
Bioorganic chemistry
Year
2024
PMID
39520787
Verification
PMID confirmed at PubMed The PMID shown was confirmed at PubMed on 2026-09-14: PubMed held a record under this identifier. This check confirms the identifier only, not the study type, the findings, or any relevance to a chemical sequence. It is held as a citation, not evidence. No tier is an endorsement, an evidence-strength rating, or independent replication, and none establishes efficacy, safety, or suitability.
Full-text availability
Bibliographic details only

Technical summary

No technical summary is published for this record.

Limitations and uncertainty

Not reported in the declared source.

Cite

Cite the study

Copper(II) aromatic heterocyclic complexes of Gatifloxacin with multi-targeting capabilities for antibacterial therapy and combating antibiotic resistance.
Wu XY, Liu QY, Jiang S, Pan ZY, Dong JH, Chen BH, Li JH, Liu YS, Liu Y, He L. Bioorganic chemistry. 2024. PMID 39520787. DOI 10.1016/j.bioorg.2024.107938

The study and its abstract belong to their authors and publisher. Cite them for anything the study found.

Report an error

If a sentence on this record does not match the abstract, tell us which one. A report starts an automatic re-check by machine. No person reads the record first.

The form takes a sentence and your note. It asks for no name and no address, and we store neither. Do not put personal details in the note.

The report form runs in the interactive page. Open this record with scripts enabled to send a report.

Corrections on this record

No correction has been recorded for this record.

Method sheet

No machine-drafted summary is published on this record. Any section shown is the abstract’s own sentence, printed as issued.